|
| Press Releases |
|
 |
|
| Tuesday, October 3, 2023 |
|
|
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101 |
| more info >> |
|
| Monday, August 28, 2023 |
|
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
| HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
| HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
| Monday, July 24, 2023 |
|
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
| Monday, April 17, 2023 |
|
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| more info >> |
|
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the US. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Indonesia at COP30: Leading Tangible Progress Toward NZE 2060, PLN at the Forefront of the National Energy Transition
Nov 15, 2025 21:00 HKT/SGT
|
|
|
寵物食品革命：兩項全球新調查揭示飼主對狗與貓永續飲食的接受度日益提升
Nov 15, 2025 12:00 HKT/SGT
|
|
|
Shoucheng Q3 Results: 30% Revenue Growth and HK$1B Buyback Plan Signal Confidence
Nov 15, 2025 10:05 HKT/SGT
|
|
|
三季报再度超预期：收入净利高增 回购升级10亿 首程控股加速迈向成长新阶段
Nov 15, 2025 10:05 HKT/SGT
|
|
|
三季報再度超預期：收入淨利高增 回購升級10億 首程控股加速邁向成長新階段
Nov 15, 2025 10:05 HKT/SGT
|
|
|
Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats
Nov 14, 2025 22:00 HKT/SGT
|
|
|
Hitachi Employee Receives the "Chop Wood Carry Water Award" from the Global OSS Organization CNCF for Leading the Establishment of Official Community in Japan
Nov 14, 2025 21:06 JST
|
|
|
Eternal Group at Cosmoprof Asia 2025, The Fragrance Frontier: How Scent is Revolutionizing Spatial Design and the Olfactory Economy
Nov 14, 2025 17:32 HKT/SGT
|
|
|
穎通集團於亞太區美容展2025 揭示香氛跨界空間設計 嗅覺經濟新浪潮
Nov 14, 2025 17:32 HKT/SGT
|
|
|
颖通集团于亚太区美容展2025 揭示香氛跨界空间设计 嗅觉经济新浪潮
Nov 14, 2025 17:32 HKT/SGT
|
|
|
Chuangxin Industries Holdings Limited, a Green Electrolytic Aluminum and Alumina Producer, Announces its Plan to List on the Main Board of the Hong Kong Stock Exchange
Nov 14, 2025 14:14: JST
|
|
|
Chuangxin Industries Holdings Limited, a Green Electrolytic Aluminum and Alumina Producer, Announces its Plan to List on the Main Board of the Hong Kong Stock Exchange
Nov 14, 2025 13:14 HKT/SGT
|
|
|
綠色電解鋁及氧化鋁生產商 創新實業集團有限公司宣佈於香港聯合交易所主板上市計劃
Nov 14, 2025 13:14 HKT/SGT
|
|
|
アリックスパートナーズ、世界のEVバッテリー業界レポートを発表
Nov 14, 2025 11:00: JST
|
|
|
創新實業今起招股 入場費約5550港元
Nov 14, 2025 09:16 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
